insights_auto
Why is ORX up 11.90%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEK 1.01
arrow_upward
+11.90%(+0.11) 1D
Nov 18, 5:29:44 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEK 0.91
High
SEK 1.07
Low
SEK 0.88
Mkt. cap
352.99M
Avg. vol.
734.04K
Volume
1.47M
P/E ratio
0.07
52-wk high
SEK 22.55
52-wk low
SEK 0.80
EPS
SEK 13.61
Shares outstanding
35.13M
No. of employees
55
Open
SEK 0.91
High
SEK 1.07
Low
SEK 0.88
Mkt. cap
352.99M
Avg. vol.
734.04K
Volume
1.47M
P/E ratio
0.07
52-wk high
SEK 22.55
52-wk low
SEK 0.80
EPS
SEK 13.61
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Gap-Down Movers for Nov. 18 Session
TradingView
·
1 hour ago
S&P 500, Nasdaq find footing as Nvidia treads water
Invezz
·
10 minutes ago
UBS predicts S&P 500 moving up 12% in 2027 but flags major risks around AI
Proactive financial news
·
58 minutes ago
MARKETS LIVE: Dow losses deepen and S&P 500 turns lower as gold slides
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com